The Ras-mitogen activated protein kinase (Ras-MAPK) pathway plays an integral role in the formation of human malignancies. Stimulation of this pathway results in phosphorylation of histone H3 at serines 10 and 28 and expression of immediate-early genes. Phosphorylated (serine 10) H3, which is also acetylated on lysine 14, is associated with immediate-early genes. In this report, we investigated the relationship between these two H3 phosphorylation events in parental and ras-transformed fibroblasts. Immunoblot analyses of two-dimensional gel patterns demonstrated that all three H3 variants were phosphorylated after stimulation of the Ras-MAPK pathway and during mitosis. Following stimulation of the Ras-MAPK pathway, H3 phosphorylated on serines 10 and 28 was excluded from regions of highly condensed chromatin and was present in increased levels in rastransformed cells. Although H3 phosphorylated at serine 10 or 28 was dynamically acetylated, H3 phosphorylated at serine 28 had a higher steady state of acetylation than that of H3 phosphorylated at serine 10. When visualized with indirect immunofluorescence, most foci of phosphorylated serine 28 H3 did not co-localize with foci of H3 phosphorylated on serine 10 or phosphoacetylated on serine 10 and lysine 14, suggesting that these two phosphorylation events act separately to promote gene expression.
Introduction
Deregulation of the Ras-mitogen activated protein kinase (Ras-MAPK) pathway has been linked to cellular transformation (Campbell and Der, 2004) . Stimulation of this pathway leads to the activation of a series of kinases, resulting in the modification of chromosomal proteins and the decondensation of chromatin Clayton and Mahadevan, 2003; Edmunds and Mahadevan, 2004; Lim et al., 2004) . The basic repeating unit in chromatin, the nucleosome, consists of 146 base pairs of DNA wrapped around a histone octamer core. One of the four core histones, histone H3 plays a pivotal role in the formation of higher order chromatin fibers (Zlatanova et al., 1998) .
Acetylation and phosphorylation of the aminoterminal tail of H3 have been linked to transcriptional activity of the associated DNA (Clayton and Mahadevan, 2003) . H3 phosphorylation at Ser-10, and more recently Ser-28, occurs in response to stimulation of the MAPK pathways involving activation of ERKs and p38 at a time when immediate-early genes are expressed (Mahadevan et al., 1991; Clayton and Mahadevan, 2003; Soloaga et al., 2003; Zhong et al., 2001a, b) . This phosphorylation is transient and correlates with transcriptional activity at immediate-early genes. Chromatin immunoprecipitation experiments have demonstrated that nucleosomes on the immediate-early genes c-fos and c-jun contain H3 phosphorylated at Ser-10 after activation of the MAPK pathway, implying that this modification plays an important role in the modulation of chromatin structure at immediate-early genes (Chadee et al., 1999; Cheung et al., 2000a; Clayton et al., 2000; Thomson et al., 2001) . Further, the mitogeninduced phosphorylated Ser-10 H3 was not confined to the promoter of the immediate-early genes, but was also present in their coding regions (Chadee et al., 1999; Clayton et al., 2000) . Following stimulation of the Ras-MAPK pathway with TPA, phosphorylation on Ser-28 follows the same temporal pattern as that on Ser-10, leading one to believe that it also has a role in immediate-early gene activity (Soloaga et al., 2003) .
It has been postulated that the phosphorylation of H3 on Ser-10 contributes to transcriptional activation by modulating chromatin structure (Chadee et al., 1999; Thomson et al., 1999) . Ras-transformed cells contain higher levels of H3 phosphorylated on Ser-10 (Chadee et al., 1999) , and like other oncogene-transformed cells display a relaxed chromatin structure that is more susceptible to nuclease digestion (Laitinen et al., 1990; Chadee et al., 1995; Taylor et al., 1995) . An additional phosphorylation of H3 on Ser-28 may contribute to chromatin remodeling and transcriptional activation in the same way, producing a more efficient means by which the cell could promote transcription.
Recent studies have demonstrated a potential role for histone variants in the transcription process. H3.3, the only H3 variant expressed outside of S phase and incorporated into chromatin in a replication-independent pathway, is enriched in transcriptionally active chromatin (Hendzel and Davie, 1990; Ahmad and Henikoff, 2002) . The other H3 variants H3.1 and H3.2 are expressed during S phase of the cell cycle. In accordance with H3.3 being associated with transcribed chromatin, Drosophila H3.3 is enriched in histone modifications associated with expressed genes including acetylation and lysine 4 methylation (McKittrick et al., 2004) . These observations agree with the idea that H3.3 is introduced into nucleosomes that are reassembled after being disrupted by the transcription process (Van Holde et al., 1992; Kireeva et al., 2002; McKittrick et al., 2004; Workman and Abmayr, 2004) .
Here we investigated the relationship between H3 phosphorylation on Ser-10 and Ser-28 after stimulation of the Ras-MAPK pathway. We demonstrate the induction of phosphorylation on the three H3 variants after activation of the Ras-MAPK pathway in both parental and ras-transformed fibroblasts. Phosphorylation of H3 on Ser-28 was also induced in c-Ha-rastransformed (Ciras-3) cells, and we found that in addition to the elevated levels of H3 phosphorylated on Ser-10 in the Ciras-3 cells, these cells also contain increased amounts of H3 phosphorylated on Ser-28. Like H3 phosphorylation at Ser-10, we found that phosphorylation of H3 on Ser-28 exists in noncondensed regions of chromatin and on H3 isoforms that were mono-, di-, or tri-modified by acetylation and/or phosphorylation. We performed immunolocalization studies to visualize the location of modified H3 in the nucleus. Our observations show that the nuclear location of H3 phosphorylated on Ser-10 was for the most part distinct from that of H3 phosphorylated on Ser-28. Our results suggest that these two H3 phosphorylation events occur independently at distinct chromatin regions.
Results
Phosphorylation of H3 on Ser-28 follows the same induction pattern as that on Ser-10 Stimulation of the Ras-MAPK signal transduction pathway in 100% confluent, serum-starved mouse 10T1/2 fibroblasts with TPA results in the temporal stimulation of phosphorylated ERKs (Espino et al., 2005) and the rapid induction of H3 phosphorylation at Ser-10. In immunoblot experiments we analysed the phosphorylation of H3 at Ser-28 following stimulation of the Ras-MAPK pathway. Figure 1a shows that the temporal induction pattern of H3 Ser-28 phosphorylation was similar to that of phosphorylation at Ser-10. Phosphorylation of Ser-10 and Ser-28 occurred in a rapid and transient manner. Phosphorylation at both sites was induced within 15 min of stimulation, decreased within 60 min, and was present only in minor amounts 90 min after stimulation began. Pretreatment of the cells with H89, an inhibitor of the ERK-activated H3 kinase (mitogen and stress activated kinase, MSK1/ 2), prevented the TPA-induced phosphorylation of H3 at Ser-10 or Ser-28 (Figure 1b) .
The TPA-induced phosphorylated Ser-10 and Ser-28 H3 was electrophoretically resolved on acetic acid-urea (AU) polyacrylamide gels, which separate histones according to size and charge. Both acetylation and phosphorylation will reduce the net positive charge of H3 resulting in the reduced migration of the isoform according to the level of modification (Cheung et al., 2000b) . As shown in Figure 2a , immunostaining of PVDF blots after AU gel separation revealed that H3 phosphorylated on Ser-10 was present in the mono-, diand tri-modified forms. After 15 min, phosphorylated Ser-10 was present in the mono-and di-modified isoforms and less so in the tri-modified isoform (Figure 2b ). Following 30 and 60 min, phosphorylated Ser-10 was primarily located in the mono-modified isoform. The AU gel pattern was also immunostained with antiphosphoacetylated (Ser-10, Lys-14) H3 antibodies (Figure 2a ). Identical to the results of others (Cheung et al., 2000b) , the majority of H3 molecules carrying this modification were only di-modified by phosphorylation and acetylation. The distribution of H3 phosphorylated at Ser-28 among the H3 isoforms was distinct from that of H3 phosphorylated at Ser-10, with phosphorylated Ser-28 being associated primarily with the tri-modified form at 15 min (Figure 2b ). After 60 min, the distribution of phosphorylated Ser-28 was tri-> mono-> di-modified H3 isoforms. The trimodified H3 isoform could be di-acetylated, phosphorylated Ser-28 or mono-acetylated, di-phosphorylated (Ser-10, Ser-28) H3. Although definitive conclusions cannot be drawn from these data sets as to the modification of the tri-modified form with phosphorylated Ser-28, the observed distribution of the phosphorylated Ser-10 and that of the acetylated Lys-14, phosphorylated Ser-10 would suggest that the trimodified form of H3 with phosphorylated Ser-28 was not di-phosphorylated, acetylated Lys-14.
Epitope occlusion has been noted with the antiphosphorylated Ser-10 H3 antibody generated by the Mahadevan group, whereby acetylation prevented the antibody from recognizing the phosphorylated Ser-10 epitope (Clayton et al., 2000) . In contrast, the Allis' antibody against phosphorylated Ser-10 recognized this epitope when Lys-14 was acetylated (Cheung et al., 2000b) . To determine whether the anti-phosphorylated Ser-10 and anti-phosphorylated Ser-28 H3 antibodies used in our studies were affected by acetylation, histones isolated from trichostatin A-and TPA-treated mouse fibroblasts were analysed by immunoblotting. Figure 2c shows that both antibodies recognized the hyperacetylated tri-and tetra-modified H3 isoforms. These results demonstrate that H3 phosphorylated at either Ser-10 or Ser-28 was localized in chromatin regions participating in dynamic acetylation.
TPA-induced phosphorylation of the three H3 variants in 10T1/2 and Ciras-3 mouse fibroblasts Histone H3 has three variants H3.1, H3.2 and H3.3. The H3.3 variant is synthesized throughout most of the cell cycle and will accumulate in the nuclear pools outside of S-phase of the cell cycle (Tagami et al., 2004) . As transcription results in the disruption of nucleosomes, the nucleosome reconstruction process specially that occurring in G0, G1 and G2 phases of the cell cycle will incorporate the available H3.3 variant into nucleosomes of transcriptionally active chromatin regions. The observation that H3.3 is enriched in transcriptionally active chromatin regions is likely a consequence of this event (Ridsdale and Davie, 1987; Waterborg, 1993; Ahmad and Henikoff, 2002; Henikoff et al., 2004; Workman and Abmayr, 2004) . We surmised that transcription of immediate-early genes in G1 phase of the cell cycle may result in these chromatin regions being enriched in H3.3, and hence the build up of H3.3 in these regions may result in H3.3 being the major acceptor of TPA-induced phosphorylation. To test this idea, histone variants isolated from 100% confluent, serum-starved and TPA-stimulated 10T1/2 mouse fibroblasts were resolved electrophoretically on a firstdimension acetic acid-urea-Triton (AUT) polyacrylamide gel, which separates histones according to size, charge and hydrophobicity, followed by electrophoresis through a SDS-15% polyacrylamide gel. The Coomassie Blue-stained two-dimensional gel pattern shown in Figure 3a containing mouse fibroblast histones shows the resolution of the three H3 variants. The distribution of phosphorylated Ser-10 and Ser-28 among the H3 variants was determined by immunostaining of histones, which were transferred onto nitrocellulose membranes from the two-dimensional gel patterns. Phosphorylation of H3 on Ser-28 or Ser-10 was not detected in the serumstarved mouse fibroblast 10T1/2 cells ( Figure 3b and data not shown). As with the 10T1/2 cells, levels of phosphorylated Ser-28 ( Figure 3c ) and phosphorylated Ser-10 (Strelkov and Davie, 2002) were increased following 15 min of TPA treatment of serum-starved Immunostaining of modified forms of H3 separated on an acetic acid-urea (AU) polyacrylamide gel with antibodies specific for phosphorylated H3 Ser-10 (pS10H3), phosphorylated H3 Ser-28 (pS28H3), and phosphorylated H3 Ser-10, acetylated Lys-14 H3 (pS10AcK14H3). Mono-, di-, tri-, and tetra-refer to the mono-, di-, tri-, and tetra-modified forms of H3, respectively. (b) Relative abundance of modified states participating in TPA-induced H3 phosphorylation. Density of bands in (a) as determined by scanning the autoradiogram on a BioRad model 1650 scanning densitometer. (c) 100% confluent, serum-starved 10T1/2 fibroblasts were treated with 100 nM TPA for 15 min followed by a combination of 100 nM TPA and 500 ng/ml TSA for 15 min. Modified forms of H3 separated on an AU polyacrylamide gel and immunostained with antibodies specific for phosphorylated H3 Ser-10 (pS10H3), phosphorylated H3 Ser-28 (pS28H3) or total H3
Ciras-3 cells. Following 15 min of TPA treatment of 10T1/2 and Ciras-3 serum-starved cells, Ser-28 phosphorylation was detected on H3.2 and H3.3 and to a lesser extent on H3.1 (Figure 3d ). Similar to the results with phosphorylated Ser-28, the three H3 variants participated in TPA-stimulated phosphorylation on Ser-10 in 10T1/2 and Ciras-3 cells (Figure 3d ). These results demonstrate that contrary to our hypothesis that H3.3 would be the principle recipient of TPA-stimulated phosphorylation, all H3 variants were phosphorylated at Ser-10 and Ser-28.
Phosphorylation of H3 at Ser-10 and Ser-28 is maximal when cells are in G2/M phase of the cell cycle (Hendzel et al., 1997; Nowak and Corces, 2004) . During this phase of the cell cycle, we postulated that all H3 variants in chromatin would be phosphorylated at Ser-10 and/or Ser-28. We compared the TPA-induced phosphorylation of the H3 variants in 10T1/2 and Ciras-3 cells with the mitosis related H3 phosphorylation. Colcemid was used to arrest parental and Ciras-3 cells in G2/M phase of the cell cycle, with 78-80% of the colcemid treated cells being in G2/M phase of the cell cycle (Table 1) . Immunochemical staining of the G2/M arrested 10T1/2 cells shows that H3 phosphorylated Ser-10 and Ser-28 colocalizes with the intensely stained DAPI pericentromeric heterochromatin regions in G2 phase, while the entire condensed chromatin was associated with phosphorylated Ser-10 and Ser-28 H3 in mitosis (Figure 4 ). Immunoblot analyses of the histones isolated from cycling and colcemid arrested 10T1/2 cells demonstrated the increased level of H3 phosphorylated at Ser-10 and Ser-28 in colcemid treated cells (Figure 5a ). Resolution of the histones from cycling or G2/M arrested 10T1/2 cells on AU polyacrylamide gels shows that H3 phosphorylated Ser-10 and Ser-28 was primarily located in the di-modified isoform (Figure 5b ). Two-dimensional (AUT into SDS) electrophoresis and subsequent immunostaining of nitrocellulose blots determined that the three H3 variants were phosphorylated at Ser-10 and Ser-28 during mitosis in 10T1/2 and Ciras-3 cells (Figure 5c ). Ser-28 phosphorylated H3 is increased in ras-transformed mouse fibroblasts
We had previously demonstrated that the levels of phosphorylated Ser-10 H3 were elevated in Ciras-3 cells (Chadee et al., 1999) . To determine if there was also an increase in the level of H3 phosphorylated on Ser-28 in the ras-transformed cells, histones extracted from a set of cell-cycle matched parental 10T1/2 and Ciras-3 cells were separated by SDS-PAGE and immunostained with antibodies specific for phosphorylated H3. As H3 phosphorylation peaks in G2/M phase (Figure 5a ), it was necessary to have the distribution of the 10T1/2 and Ciras-3 cells in the various cell cycle phases matched as closely as possible. Table 1 shows that the distribution of parental (10T1/2) cells in the cell cycle phases was similar to that of the Ciras-3 cells, although the 10T1/2 cells had a 3-4% greater amount of G2/M phase cells than that of Ciras-3 cells. Figure 5d revealed that the level of H3 phosphorylated on Ser-28 was more abundant in Ciras-3 than in the parental 10T1/2 even though the 10T1/2 had a slightly greater amount of the H3 phosphorylation rich G2/M phase cells. Most cycling Ciras-3 cells were in G1 phase of the cell cycle. We had reported previously that the phosphorylated Ser-10 H3 in G1 phase Ciras-3 cells was localized in relaxed chromatin regions outside of condensed pericentromeric heterochromatin (Chadee et al., 1999) . We investigated whether phosphorylated Ser-28 H3 had a similar distribution. The subcellular localization of phosphorylated H3 in Ciras-3 cells was determined by indirect immunofluorescence (Figure 6 ). Antibodies specific for phosphorylated Ser-28 H3 or for phosphorylated Ser-10 H3 stained small foci within the nucleus of cycling Ciras-3 cells, with the majority of these foci appearing outside of regions of condensed chromatin. The intense DAPI staining shown in Figure 6 corresponds to the condensed AT-rich pericentromeric heterochromatin (Chadee et al., 1999) . These results suggest that phosphorylated Ser-10 H3 and phosphorylated Ser-28 H3 in Ciras-3 cells are associated with relaxed potentially transcriptionally competent chromatin regions.
Phosphorylation of H3 on Ser-28 occurs independently of phosphorylation on Ser-10
In Figure 2 , TPA-induced phosphorylated Ser-28 H3 was detected in the mono-, di-, and tri-modified forms of H3, with a smaller fraction existing in a tetra-modified form. Phosphorylated Ser-10 H3 existed in these fractions as well, but with a different distribution. Detection of a significant portion of Ser-28 phosphorylation in the mono-modified form indicated that this phosphorylation event was not dependent upon phosphorylation at Ser-10 and vice versa. To further investigate the relationship between H3 Ser-10 and Ser-28 phosphorylation and acetylation events, we determined the location of phosphorylated Ser-10 H3, phosphorylated Ser-28 H3 and phosphorylated Ser-10, acetylated Lys-14 H3 in the nucleus of 10T1/2 mouse fibroblasts. Indirect immunofluorescence was performed in mouse fibroblasts that had been grown to 100% confluence and serum-starved for 24 h. Antibodies specific for phosphorylated Ser-10 H3, phosphorylated Ser-28 H3 and phosphorylated Ser-10, acetylated Lys-14 H3 detected many small foci of modified H3 after stimulation with TPA for 15 min ( Figure 7 ). As found by Chadee et al. (1999) foci of phosphorylated Ser-10 H3 were not located in regions of intense DAPI staining at pericentromeric heterochromatin. We observed that foci of phosphorylated Ser-28 H3 and phosphorylated Ser-10, acetylated Lys-14 H3 were also excluded from highly condensed chromatin. Although phosphorylated Ser-10 H3 and phosphorylated Ser-28 H3 had similar distributions, most of the phosphorylated Ser-10 foci did not colocalize with the phosphorylated Ser-28 H3 foci. Likewise, many of the phosphorylated Ser-28 H3 foci did not colocalize with foci of phosphoacetylated H3 (Figure 7b ). These observations demonstrate that for the most part the chromatin regions participating in TPA-induced phosphorylation of H3 on Ser-10 were distinct from those where phosphorylation of H3 occurs on Ser-28.
Discussion
Stimulation of the Ras-MAPK pathway by growth factors or phorbol esters (TPA) results in the transient increase in phosphorylated active ERKs (Espino et al., 2005) . The TPA-induced phosphorylation of H3 parallels the temporal stimulation of the ERKs, with Table 1 ) were separated on SDS-15% polyacrylamide gels and analysed by immunoblot. The blots were immunostained with antibodies against phosphorylated H3 Ser-10 (pS10H3), against phosphorylated H3 Ser-28 (pS28H3), and against total H3 Figure 6 Localization of phosphorylated H3 in Ciras-3 cells. Indirect immunofluorescence to detect phosphorylated H3 Ser-28 (pS28 H3, top panel) or Ser-10 (pS10 H3, bottom panel) was performed on cycling Ciras-3 cells. Cells were co-stained with DAPI. Digital optical sections of 0.25 mm were obtained and false-coloured green (pS28 H3), red (pS10 H3) or blue (DAPI) Figure 7 Phosphorylation of H3 on Ser-28 occurs independently of phosphorylation on Ser-10. 10T1/2 fibroblasts were grown to 100% confluence, serum-starved for 24 h, and treated with TPA for 15 min before fixation for indirect immunofluorescence with antibodies recognizing phosphorylated H3 Ser-10 (pS10 H3), phosphorylated H3 Ser-28 (pS28 H3), and H3 that is phosphorylated on Ser-10 and acetylated on Lys-14 (pS10AcK14 H3). Digital optical sections were obtained and false coloured green (pS28 H3), red (pS10 H3, PS10AcK14 H3) or blue (DAPI)
Phosphorylation of H3 on serine 28 KL Dunn and JR Davie phosphorylated ERK and phosphorylated H3 levels being maximal at 30 min (Espino et al., 2004) . Previous studies demonstrated that inhibition of the Ras-MAPK with the MEK inhibitors PD98059 or UO126 prevented the TPA-induced Ser-10 and Ser-28 phosphorylation of H3, demonstrating that TPA-induced H3 phosphorylation was a consequence of stimulation of the Ras-MAPK pathway (Strelkov and Davie, 2002; Soloaga et al., 2003) . Constitutive stimulation of the Ras-MAPK pathway in oncogene (ras)-transformed cells results in an increased steady state of phosphorylated active ERKs (Drobic et al., 2004) and of Ser-10 and Ser-28 phosphorylated H3 (this study). The H3 kinase responsive to TPA or oncogene activated Ras-MAPK pathway is the mitogen and stress activated protein kinase (MSK1/2) (Drobic et al., 2004) . Inhibition of MSK1/2 activity with H89 prevents H3 phosphorylation in TPAinduced serum-starved 10T1/2 and Ciras-3 cells. We observed many similarities in the phosphorylation of H3 at Ser-10 and Ser-28. Both modifications are induced by the same stimuli, disappear within the same time frame, and are located within relatively relaxed chromatin conformations. Further, the ras-transformed cells contain increased amounts of H3 phosphorylated at Ser-10 and Ser-28. These observations suggest that these two modifications work together. However, AU gel analyses determined that a significant portion of phosphorylated Ser-28 and phosphorylated Ser-10 exist on an H3 that has not been otherwise acetylated or phosphorylated (the mono-modified form), suggesting that the two modifications do not function in a cooperative manner. Furthermore, this mono-modified form was present in significant amounts 15 and 30 min after stimulation of the pathway began, the time when we observe phosphorylation to be at a maximum. Thus, phosphorylation of Ser-28 is not dependent upon the phosphorylation of Ser-10 or vice versa. Further, although MSK1/2, the kinase mediating mitogeninduced phosphorylation of H3, is capable of phosphorylating H3 on either residue (Davie, 2003; Lim et al., 2004) , our results suggest that the enzyme selects either Ser-10 or Ser-28 but not both sites for phosphorylation of the H3 tail.
Following TPA stimulation of 10T1/2 mouse fibroblasts, the distribution of Ser-10 phosphorylated H3 among the modified H3 isoforms is quite distinct from that of Ser-28 phosphorylated forms. Ser-10 phosphorylated H3 reside in poorly modified isoforms (primarily mono-modified at 30 and 60 min post-TPA addition), while phosphorylated Ser-28 is present in highly modified isoforms (primarily tri-modified). A combination of H3 (Ser-10) phosphorylation and acetylation has been detected on immediate-early genes with the chromatin immunoprecipitation assay (Cheung et al., 2000b; Clayton et al., 2000; Thomson et al., 2001) , providing evidence that a sub-population of phosphorylated Ser-10 H3 in the di-modified band is also modified by acetylation on Lys-14. Our results with an antibody against phosphorylated Ser-10, acetylated Lys-14 H3 detected the vast majority of H3 tails modified by this combination of acetylation and phosphorylation in the di-modified band in agreement with a previous report (Cheung et al., 2000b) . It is thus possible that the dimodified form with phosphorylated Ser-10 H3 is phosphoacetylated rather than being di-phosphorylated at Ser-10 and Ser-28. Conversely, the di-and trimodified Ser-28 phosphorylated forms may represent monophosphorylated and mono-acetylated or di-acetylated forms, respectively. This striking difference suggests that TPA-induced H3 Ser-28 phosphorylation occurs in chromatin domains that have a higher steady-state level of acetylation than those regions undergoing phosphorylation at H3 Ser-10. However, H3 phosphorylated at either Ser-10 or Ser-28 is localized in dynamically acetylated chromatin regions, which can be driven into highly acetylated states when the histone deacetylase activity is inhibited with trichostatin A. It has been demonstrated directly that TPA-induced Ser-10 H3 is associated with immediate early genes c-fos, cmyc and c-jun (Chadee et al., 1999; Clayton et al., 2000) . The observation that Ser-28 phosphorylated H3 is engaged in dynamic acetylation typically linked to transcribed chromatin suggests that this phosphorylated H3 is also associated with genes responding to a stimulated Ras-MAPK pathway (Schubeler et al., 2004) . However, our results suggest that the genes associated with H3 phosphorylated at Ser-10 will differ from those bound to H3 phosphorylated at Ser-28.
Indirect immunofluorescence allowed us to observe the location of various modified forms of H3 after stimulation of the Ras-MAPK pathway. The numerous foci that appeared upon TPA treatment were excluded from pericentromeric heterochromatin and were present in regions of more relaxed chromatin, a finding that supports phosphorylated Ser-28 H3 involvement in the transcriptional process. In agreement with previous findings that phosphorylated Ser-10 H3 and phosphorylated Ser-10, acetylated Lys-14 H3 are involved in gene expression, foci of these modified forms of H3 were also found in regions of relatively decondensed chromatin after TPA stimulation. Surprisingly, many foci of phosphorylated Ser-28 H3 were found in areas where phosphorylated Ser-10 H3 was absent, indicating that some form of regulation exists that allows these two modifications to be targeted separately. We estimate that 83% of H3 phosphorylated at Ser-10 or Ser-28 did not co-localize. Areas of phosphorylated Ser-28 H3 were also located outside of regions where H3 was modified by a combination of phosphorylation at Ser-10 and acetylation at Lys-14. Thus, the modification events associated with H3 Ser-10 phosphorylation are distinct from those of H3 phosphorylation at Ser-28, a large percentage of the time. Therefore the di-and trimodified bands of H3 modified by phosphorylation at Ser-28 are unlikely to be di-phosphorylated, but rather mono-or di-acetylated and mono-phosphorylated.
During G2-M phase of the cell cycle, H3 in chromatin is globally phosphorylated by the kinase Aurora B at Ser-10 and Ser-28. The maximal phosphorylation of H3 and the participation of all H3 variants during this period in the cell cycle provided a reference for H3 phosphorylation events occurring during TPA-induced H3 phosphorylation of serum-starved G1 phase 10T1/2 mouse fibroblasts and Ciras-3 cells. In contrast to mitogen-induced MSK1/2-mediated H3 phosphorylation, Aurora B phosphorylated H3 is poorly acetylated (Kruhlak et al., 2001) . In analyses of the distribution of the modified H3 isoforms with Ser-10 and Ser-28 phosphorylation, we observed that mitotic H3 phosphorylated on Ser-10 or Ser-28 was found mainly on an H3 tail that is modified by one other phosphorylation or acetylation event (the di-modified form). Given the general absence of hyperacetylated H3 during mitosis, we suggest that the di-modified forms of phosphorylated H3 are most likely di-phosphorylated.
Recent reports in the literature have linked histone variant H3.3 with transcriptional activity (Ahmad and Henikoff, 2002; McKittrick et al., 2004; Workman and Abmayr, 2004) . Chromatin immunoprecipitation assays have found H3 phosphorylated on Ser-10 in the chromatin associated with immediate-early genes during transcription (Chadee et al., 1999; Cheung et al., 2000b; Clayton et al., 2000; Thomson et al., 2001) . Therefore, if the chromatin associated with immediate-early genes is enriched in H3.3, we would expect the induction of the Ras-MAPK pathway to result in a disproportionate increase in the amount of H3.3 phosphorylated on Ser-10 as compared to the other H3 variants. The same would be expected of phosphorylation on Ser-28 if this modification is occurring at genes expressed following stimulation of the Ras-MAPK pathway. In contrast to our expectations, we observed that H3.2, H3.3 and to a lesser extent H3.1 was phosphorylated at Ser-28 and that all three H3 variants participated in TPA-induced phosphorylation at Ser-10 in TPA-stimulated serumstarved 10T1/2 mouse fibroblasts and Ciras-3 cells. The differing level of phosphorylation of H3.1 at Ser-10 versus Ser-28 further supports our results that H3 phosphorylated at Ser-10 is located in different chromatin regions from that of H3 phosphorylated at Ser-28. The observation that H3.3 was not selectively phosphorylated at Ser-10 or Ser-28 suggests that nucleosomes in the transcription unit are not reassembled with only H3.3 following transcriptional disruption of nucleosome structure. However, chromatin immunoprecipitation assays have shown that the TPA-induced phosphorylated (Ser-10) H3 is also localized with the promoter of immediate-early genes. Promoter nucleosomes would be susceptible to chromatin remodeling events but not the disruptive path of the transcription machinery. Thus, nucleosomes at the promoter may have an H3 variant composition similar to that of bulk chromatin. Another consideration is that H3 phosphorylation may exceed the confines of the transcription unit and may occur throughout a chromatin domain in a manner similar to that observed for acetylated H3 and Lys-4 methylated H3 (Litt et al., 2001) .
In addition to the increase in phosphorylated Ser-10 H3, oncogene-transformed cells often display defects in nuclear architecture including irregular nuclear matrix profiles (Samuel et al., 1997) and abnormal nuclear morphologies (Fischer et al., 1998) . Increased levels of phosphorylated Ser-28 H3 in ras-transformed cells may contribute, along with these defects, to the relaxed chromatin structure and aberrant gene expression observed in these cells. Elucidation of the mechanism by which phosphorylation at Ser-10 is distinct from phosphorylation on Ser-28 and determination of the specific subsets of genes affected by these modifications may provide new targets for therapeutic agents in cancer therapy.
Materials and methods

Antibodies
Rat monoclonal antibody against phos-H3S28 was purchased from Sigma Chemical Company (Saint Louis, MO, USA) and used for both immunoblotting and immunofluorescence. Antibodies to phosphorylated Ser-10 H3 were purchased from New England Biolabs Ltd. (Pickering, Ontario, Canada) and Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal antibodies against H3 and phosphorylated Ser-10, acetylated Lys-14 H3 were purchased from New England Biolabs Ltd (Pickering, Ontario, Canada). FITC-conjugated rabbit anti-rat was purchased from Sigma. Cy3-conjugated sheep anti-rabbit was purchased from Sigma.
Cell lines and tissue culture
Ciras-3 cells were derived from parental 10T1/2 mouse fibroblasts by transforming with T-24 Ha-ras oncogene (Egan et al., 1987) . 10T1/2 and Ciras-3 mouse fibroblasts were cultured in a-MEM (Invitrogen Corporation) containing 10% (v/v) fetal bovine serum (CanSera, Ontario, Canada), 100 U/ ml penicillin G sodium, 100 mg/ml streptomycin sulfate and 0.25 mg/ml amphoteracin B (Invitrogen Corporation). Cycling cells were harvested at 70% confluence. To arrest cells in mitosis, cells were cultured to 70% confluence before treatment with 0.06 mg/ml colcemid for 16 h before harvesting. To obtain G0 phase cells, cells were grown to 100% confluence and then washed twice with PBS before being cultured in a-MEM containing 0.1% fetal bovine serum for 24 h (10T1/2) or 48 h (Ciras-3). Quiescent cells were stimulated with TPA (100 nM) for various times. When required, quiescent cells were treated with 10 mM H89 (Calbiochem, La Jolla, CA, USA) for 30 min prior to stimulation with TPA for 15 min. Cells treated with trichostatin A (Sigma Chemical Company, St Louis, MO, USA) were first stimulated with TPA for 15 min and then treated with a combination of 100 nM TPA and 500 ng/ml trichostatin A for 15 min. After treatment, cells were rinsed twice with PBS and harvested with 0.2% trypsin-EDTA, pelleted and kept at À701C until further analysed. The cell cycle distribution of harvested cells was determined by flow cytometric analysis.
Electrophoresis and immunoblotting
Histone samples were separated by SDS-15% polyacrylamide gel electrophoresis. Samples were then transferred onto nitrocellulose (Biorad) as previously described (Chadee et al., 1999) . Immunochemical staining was then performed using antibodies specific for histone H3, H3 phosphorylated on Ser-10 or H3 phosphorylated on Ser-28. Detection of proteins was carried out with the use of the enhanced chemiluminescence detection system from Amersham Pharmacia Biotech as described previously (Chadee et al., 1999) .
